RECALL ADVICE TO GLOBAL PHARMACEUTICALS: PANTODENK( PANTOPRAZOLE 40MG)- Recall due to Out-of-Specification result in ongoing stability study with resultant change in appearance of several tablets ( dark discoloration) leading to considerable impurities.
塞拉利昂药房委员会于 4 月 25 日向 Global Pharmaceuticals-UB Pharm Limited 54 Regent Road Hill Station 发布了关于 Pantodenk（泮托拉唑 40mg）的召回建议，原因是其供应商之一报告存在大量杂质。
欲了解更多信息，请联系塞拉利昂药房委员会；
info@pharmacyboard.gov 099117117 和塞拉利昂药房委员会的药物评估和注册部。